select a format

Single User License
USD 4000 INR 256360
Site License
USD 8000 INR 512720
Corporate User License
USD 12000 INR 769080

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Peripheral Vascular Stents-Medical Devices Pipeline Assessment, 2016

Peripheral Vascular Stents-Medical Devices Pipeline Assessment, 2016


  • Products Id :- GDME0293EPD
  • |
  • Pages: 213
  • |
  • December 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Peripheral Vascular Stents-Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Peripheral Vascular Stents-Medical Devices Pipeline Assessment, 2016" provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Peripheral Vascular Stents under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Peripheral Vascular Stents under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 12

2 Introduction 13

2.1 Peripheral Vascular Stents Overview 13

3 Products under Development 14

3.1 Peripheral Vascular Stents-Pipeline Products by Stage of Development 14

3.2 Peripheral Vascular Stents-Pipeline Products by Segment 15

3.3 Peripheral Vascular Stents-Pipeline Products by Territory 16

3.4 Peripheral Vascular Stents-Pipeline Products by Regulatory Path 17

3.5 Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date 18

3.6 Peripheral Vascular Stents-Ongoing Clinical Trials 19

4 Peripheral Vascular Stents-Pipeline Products under Development by Companies 20

4.1 Peripheral Vascular Stents Companies-Pipeline Products by Stage of Development 20

4.2 Peripheral Vascular Stents-Pipeline Products by Stage of Development 22

5 Peripheral Vascular Stents Companies and Product Overview 25

5.1 3D Biotek LLC Company Overview 25

5.2 480 Biomedical Inc Company Overview 26

5.3 Abbott Vascular Inc. Company Overview 30

5.4 Biotronik SE & Co KG Company Overview 32

5.5 Boston Scientific Corp Company Overview 37

5.6 C. R. Bard Inc Company Overview 43

5.7 Cardiatis SA Company Overview 45

5.8 Cook Medical Inc Company Overview 46

5.9 Cordis Corp Company Overview 58

5.10 Corinnova Inc Company Overview 62

5.11 Cytograft Tissue Engineering Inc Company Overview 63

5.12 Efferent Labs Inc Company Overview 64

5.13 Electroformed Stents Inc Company Overview 65

5.14 Elixir Medical Corp Company Overview 68

5.15 Hexacath Company Overview 70

5.16 InspireMD Inc Company Overview 72

5.17 Intact Vascular, LLC Company Overview 74

5.18 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 77

5.19 LimFlow GmbH Company Overview 79

5.20 Medinol Ltd Company Overview 81

5.21 Medtronic plc Company Overview 83

5.22 MicroVention, Inc. Company Overview 85

5.23 Natec Medical Ltd Company Overview 86

5.24 Nexeon MedSystems Inc Company Overview 87

5.25 Nipro Corp Company Overview 89

5.26 Northwestern University Company Overview 91

5.27 NSVascular, Inc. Company Overview 92

5.28 PeriTec Biosciences Ltd Company Overview 94

5.29 Stron Medical Company Overview 96

5.30 Synergy Flow Ltd Company Overview 98

5.31 Taewoong Medical Co.,Ltd. Company Overview 99

5.32 Tepha Inc Company Overview 109

5.33 TissueGen Inc Company Overview 110

5.34 University of Michigan Company Overview 112

5.35 University of Texas Medical Branch at Galveston Company Overview 113

5.36 Vascular Bioresorbable Technologies Company Overview 114

5.37 Vascular Concepts Ltd Company Overview 116

5.38 Veniti Inc Company Overview 119

5.39 Veryan Medical Limited Company Overview 122

5.40 VueKlar Cardiovascular Ltd Company Overview 126

5.41 Xenogenics Corporation Company Overview 129

6 Peripheral Vascular Stents- Recent Developments 132

6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 132

6.2 Nov 21, 2016: VEITHsymposium 2016: BIOTRONIK Showcases Positive Results for Pulsar-18 Stent in the SFA 134

6.3 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion 135

6.4 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 135

6.5 Nov 15, 2016: Final Patient Enrolled for Iliofemoral Venous Stent Study 136

6.6 Nov 15, 2016: LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia Technology Designed to Restore Perfusion for "No Option" Patients 136

6.7 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 137

6.8 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million 138

6.9 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 138

6.10 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 140

6.11 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 142

6.12 Oct 31, 2016: FDA Approves TOBA II BTK Pivotal IDE Clinical Study 143

6.13 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 144

6.14 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 145

6.15 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 146

6.16 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 147

6.17 Oct 25, 2016: Bard Announces Third Quarter Results 149

6.18 Oct 24, 2016: Boston Scientific announced key Presentations on Eluvia Drug-Eluting Vascular Stent System at Transcatheter Cardiovascular Therapeutics 2016 149

6.19 Oct 20, 2016: Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA Bioresorbable Scaffold for Peripheral Vascular Disease 150

6.20 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 151

6.21 Oct 18, 2016: LimFlow Names Daniel Rose as Chief Executive Officer 153

6.22 Oct 11, 2016: Tepha Enters into Agreement with Metabolix 154

6.23 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 154

6.24 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 155

6.25 Sep 27, 2016: Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer 156

6.26 Sep 15, 2016: STENTYS Reports 2016 First-Half Results 156

6.27 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 157

6.28 Sep 08, 2016: VENITI Raises USD25 Million in Series D Equity Financing 158

6.29 Sep 07, 2016: GORE VIABAHN Endoprosthesis Marks 20 Years of Proven Performance 158

6.30 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 159

6.31 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 160

6.32 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 160

6.33 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 163

6.34 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 165

6.35 Aug 03, 2016: EndoChoice Announces Second Quarter 2016 Financial Results 167

6.36 Aug 02, 2016: GORE TIGRIS Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease 169

6.37 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 170

6.38 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 171

6.39 Jul 27, 2016: CONMED Announces Second Quarter 2016 Financial Results 172

6.40 Jul 26, 2016: Merit Medical Announces Appointment of New Director 173

6.41 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 173

6.42 Jul 26, 2016: Bard Announces Second Quarter Results 175

6.43 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 176

6.44 Jul 21, 2016: Svelte Medical Systems Raises USD4 Million in Venture Financing 176

6.45 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 176

6.46 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 178

6.47 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 179

6.48 Jul 12, 2016: STENTYS: 41% Increase in Revenues in the Second Quarter of 2016 180

6.49 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 180

6.50 Jul 04, 2016: STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO 181

6.51 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 181

6.52 Jun 29, 2016: InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 182

6.53 Jun 28, 2016: GORE VIABAHN Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases 182

6.54 Jun 20, 2016: VENITI Announces 1,000th Patient Treated With VICI VENOUS STENT 183

6.55 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 183

6.56 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 184

6.57 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 184

6.58 May 13, 2016: Boston Scientific Announces Presentation of Eluvia stent system at EuroPCR 2016 187

6.59 May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 187

6.60 May 04, 2016: Positive Twelve-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at SCAI 2016 189

6.61 May 02, 2016: A.G. Schneiderman Announces $306 Million National Settlement With Olympus 190

6.62 Apr 29, 2016: Neovasc Reports First Quarter Results for 2016 190

6.63 Apr 21, 2016: VENITI Completes First Use Of VICI VERTO VENOUS STENT, Novel Venous Stent System 193

6.64 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results 193

6.65 Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 196

6.66 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 196

6.67 Apr 04, 2016: AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer 197

6.68 Mar 29, 2016: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015 198

6.69 Mar 16, 2016: STENTYS Reports 2015 Annual Results 201

6.70 Mar 15, 2016: InspireMD Raises USD0.6 Million in Private Placement of Shares and Warrants 202

6.71 Mar 04, 2016: Palmaz Scientific Announces Chapter 11 Filing; Seeks Prospective Buyers for Its Breakthrough Technology 202

6.72 Feb 22, 2016: Boston Scientific Receives CE Mark For Eluvia Drug-Eluting Vascular Stent And Announces Initiation Of New Clinical Trial 203

6.73 Feb 12, 2016: Stentys Raises USD14.3 Million in Rights Offering of Shares 204

6.74 Feb 08, 2016: STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication 205

6.75 Jan 26, 2016: Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016 205

6.76 Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 206

6.77 Jan 07, 2016: AngioDynamics Reports Fiscal 2016 Second Quarter Results 207

7 Appendix 209

7.1 Methodology 209

7.2 About GlobalData 212

7.3 Contact Us 212

7.4 Disclaimer 212

1.2 List of Figures

Figure 1: Peripheral Vascular Stents-Pipeline Products by Stage of Development 15

Figure 2: Peripheral Vascular Stents-Pipeline Products by Segment 16

Figure 3: Peripheral Vascular Stents-Pipeline Products by Territory 17

Figure 4: Peripheral Vascular Stents-Pipeline Products by Regulatory Path 18

Figure 5: Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date 19

Figure 6: Peripheral Vascular Stents-Ongoing Clinical Trials 20

1.1 List of Tables

Table 1: Peripheral Vascular Stents-Pipeline Products by Stage of Development 15

Table 2: Peripheral Vascular Stents-Pipeline Products by Segment 16

Table 3: Peripheral Vascular Stents-Pipeline Products by Territory 17

Table 4: Peripheral Vascular Stents-Pipeline Products by Regulatory Path 18

Table 5: Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date 19

Table 6: Peripheral Vascular Stents-Ongoing Clinical Trials 20

Table 7: Peripheral Vascular Stents Companies-Pipeline Products by Stage of Development 21

Table 8: Peripheral Vascular Stents-Pipeline Products by Stage of Development 23

Table 9: 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent-Product Status 26

Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent-Product Description 26

Table 12: 480 Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Table 13: Stanza Bioresorbable Pediatric Scaffold-Product Status 27

Table 14: Stanza Bioresorbable Pediatric Scaffold-Product Description 28

Table 15: Stanza Bioresorbable Self-Expanding Scaffold-Product Status 28

Table 16: Stanza Bioresorbable Self-Expanding Scaffold-Product Description 29

Table 17: 480 Biomedical Inc-Ongoing Clinical Trials Overview 30

Table 18: Stanza Bioresorbable Self-Expanding Scaffold-An Evaluation of the 480 Biomedical STANZA Drug-Eluting Resorbable Scaffold (DRS) System in the Treatment of de Novo SFA Lesions 30

Table 19: Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 20: ESPRIT Bioresorbable Vascular Scaffold-Product Status 31

Table 21: ESPRIT Bioresorbable Vascular Scaffold-Product Description 32

Table 22: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 33

Table 23: Astron Pulsar Self Expanding Peripheral Stent-Product Status 33

Table 24: Astron Pulsar Self Expanding Peripheral Stent-Product Description 34

Table 25: Pulsar-18 Self Expanding Stent-Product Status 34

Table 26: Pulsar-18 Self Expanding Stent-Product Description 35

Table 27: Biotronik SE & Co KG-Ongoing Clinical Trials Overview 35

Table 28: Astron Pulsar Self Expanding Peripheral Stent-The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe) 36

Table 29: Pulsar-18 Self Expanding Stent-BIOFLEX PEACE All-comers Trial 37

Table 30: Pulsar-18 Self Expanding Stent-Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease with the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing with 4EVER Trial Results) (BIOLUX 4EVER) 37

Table 31: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 38

Table 32: Cobalt-Chromium Iliac Balloon Expandable Stent-Product Status 38

Table 33: Cobalt-Chromium Iliac Balloon Expandable Stent-Product Description 39

Table 34: Eluvia Drug-Eluting Vascular Stent System-Product Status 39

Table 35: Eluvia Drug-Eluting Vascular Stent System-Product Description 39

Table 36: Gallbladder Drainage System-Product Status 40

Table 37: Gallbladder Drainage System-Product Description 40

Table 38: Wallstent RP Endoprosthesis-Venous Outflow Obstruction-Product Status 40

Table 39: Wallstent RP Endoprosthesis-Venous Outflow Obstruction-Product Description 41

Table 40: Boston Scientific Corp-Ongoing Clinical Trials Overview 41

Table 41: Eluvia Drug-Eluting Vascular Stent System-A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries 42

Table 42: Eluvia Drug-Eluting Vascular Stent System-A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries 42

Table 43: Eluvia Drug-Eluting Vascular Stent System-Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project with Boston Scientific's Innova Drug Eluting Stent 43

Table 44: Wallstent RP Endoprosthesis-Venous Outflow Obstruction-Sinai Vein Stent Registry 43

Table 45: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 46: VENOVO Venous Stent-Product Status 44

Table 47: VENOVO Venous Stent-Product Description 45

Table 48: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 46

Table 49: Cardiatis FluidSmart 3D Stent-Product Status 46

Table 50: Cardiatis FluidSmart 3D Stent-Product Description 46

Table 51: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 52: Evolution Biliary Stent System-Partially Covered-Product Status 47

Table 53: Evolution Biliary Stent System-Partially Covered-Product Description 48

Table 54: Evolution Esophageal Stent System-Fully Covered-Product Status 48

Table 55: Evolution Esophageal Stent System-Fully Covered-Product Description 48

Table 56: Zenith Connection Endovascular Covered Stent-Product Status 49

Table 57: Zenith Connection Endovascular Covered Stent-Product Description 49

Table 58: Zenith Helical Branch Iliac Endovascular Graft-Product Status 49

Table 59: Zenith Helical Branch Iliac Endovascular Graft-Product Description 50

Table 60: ZILVER PTX Drug Eluting Peripheral Stent-Product Status 50

Table 61: ZILVER PTX Drug Eluting Peripheral Stent-Product Description 51

Table 62: Zilver Vena Venous Self-Expanding Stent-Product Status 51

Table 63: Zilver Vena Venous Self-Expanding Stent-Product Description 52

Table 64: Cook Medical Inc-Ongoing Clinical Trials Overview 53

Table 65: ZILVER PTX Drug Eluting Peripheral Stent-A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries 54

Table 66: ZILVER PTX Drug Eluting Peripheral Stent-Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions 54

Table 67: ZILVER PTX Drug Eluting Peripheral Stent-Comparison of the Primary Long Versus Short Coverage with Drug-Eluting Stents for Long Femoropopliteal Artery Disease (PARADE II): Investigator-initiated Clinical Study 54

Table 68: ZILVER PTX Drug Eluting Peripheral Stent-Drug Eluting Stent for the Management of Peripheral Arterial Disease of the SFA (DESPERADO-SFA Study) 55

Table 69: ZILVER PTX Drug Eluting Peripheral Stent-Evaluation of the Zilver PTX Drug-eluting Peripheral Stent for Treatment of Lesions of the Above-the-knee Femoropopliteal Artery 55

Table 70: ZILVER PTX Drug Eluting Peripheral Stent-Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses 55

Table 71: ZILVER PTX Drug Eluting Peripheral Stent-The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS) 56

Table 72: ZILVER PTX Drug Eluting Peripheral Stent-Zilver PTX Drug-eluting Peripheral Stent Post-approval Study 56

Table 73: ZILVER PTX Drug Eluting Peripheral Stent-Zilver PTX Post-market Surveillance Study of Paclitaxel-eluting Stents for Treating Femoropopliteal Artery Disease in Japan 57

Table 74: Zilver Vena Venous Self-Expanding Stent-Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction 57

Table 75: Evolution Esophageal Stent System-Fully Covered-Clinical Investigation to Evaluate Removal of the Evolution Esophageal Stent-Fully Covered 58

Table 76: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 59

Table 77: FlexStent Femoropopliteal Self Expanding Stent System-SFA-Product Status 59

Table 78: FlexStent Femoropopliteal Self Expanding Stent System-SFA-Product Description 60

Table 79: FlexStent Self Expanding Below-The-Knee Venous Stent System-Product Status 60

Table 80: FlexStent Self Expanding Below-The-Knee Venous Stent System-Product Description 60

Table 81: FlexStent Self Expanding Venous Stent System-Product Status 61

Table 82: FlexStent Self Expanding Venous Stent System-Product Description 61

Table 83: Tibial SE FlexStent-Product Status 61

Table 84: Tibial SE FlexStent-Product Description 62

Table 85: Cordis Corp-Ongoing Clinical Trials Overview 62

Table 86: FlexStent Femoropopliteal Self Expanding Stent System-SFA-Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-expanding Stent System Study 62

Table 87: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 88: Hybrid Dynamic Stent-Product Status 63

Table 89: Hybrid Dynamic Stent-Product Description 63

Table 90: Cytograft Tissue Engineering Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Table 91: LifeJacket Stent Graft-Peripheral-Product Status 64

Table 92: LifeJacket Stent Graft-Peripheral-Product Description 64

Table 93: Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Table 94: RTI-LICD Plexisense-Product Status 65

Table 95: RTI-LICD Plexisense-Product Description 65

Table 96: Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Table 97: Helical Stent-Product Status 66

Table 98: Helical Stent-Product Description 66

Table 99: Patch Stent-Product Status 67

Table 100: Patch Stent-Product Description 67

Table 101: Pleated Stent-Product Status 67

Table 102: Pleated Stent-Product Description 68

Table 103: Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 69

Table 104: PRAVA Bioresorbable Scaffold-Product Status 69

Table 105: PRAVA Bioresorbable Scaffold-Product Description 70

Table 106: Elixir Medical Corp-Ongoing Clinical Trials Overview 70

Table 107: PRAVA Bioresorbable Scaffold-Drug Eluting Scaffold with an Absorbable Platform for Primary Lower Extremity Arterial Revascularization (DESappear Study) 70

Table 108: Hexacath Pipeline Products & Ongoing Clinical Trials Overview 71

Table 109: HELIOS LD Peripheral Balloon Expandable Bio Active Stent-Product Status 71

Table 110: HELIOS LD Peripheral Balloon Expandable Bio Active Stent-Product Description 72

Table 111: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Table 112: PVGuard Peripheral-Product Status 73

Table 113: PVGuard Peripheral-Product Description 74

Table 114: Intact Vascular, LLC Pipeline Products & Ongoing Clinical Trials Overview 75

Table 115: Tack Endovascular System-BTK-Product Status 75

Table 116: Tack Endovascular System-BTK-Product Description 75

Table 117: Intact Vascular, LLC-Ongoing Clinical Trials Overview 76

Table 118: Tack Endovascular System-BTK-Prospective, Multicenter Tack Optimized Balloon Angioplasty below the Knee (TOBA-BTK) Study for Infrapopliteal Arteries Using the Tack-it Endovascular System 76

Table 119: Tack Endovascular System-BTK-Tack Optimized Balloon Angioplasty Study for the below the Knee Arteries Using the Tack Endovascular System 77

Table 120: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78

Table 121: Peripheral Bare Stent-Product Status 78

Table 122: Peripheral Bare Stent-Product Description 78

Table 123: Peripheral Cover Stent-Product Status 79

Table 124: Peripheral Cover Stent-Product Description 79

Table 125: LimFlow GmbH Pipeline Products & Ongoing Clinical Trials Overview 80

Table 126: LimFlow Stent Graft System-Product Status 80

Table 127: LimFlow Stent Graft System-Product Description 81

Table 128: Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

Table 129: ChampioNIR-Product Status 82

Table 130: ChampioNIR-Product Description 83

Table 131: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 84

Table 132: Maris-Product Status 84

Table 133: Maris-Product Description 85

Table 134: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

Table 135: CASPER Carotid Stent-Product Status 86

Table 136: CASPER Carotid Stent-Product Description 86

Table 137: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

Table 138: Marina-Product Status 87

Table 139: Marina-Product Description 87

Table 140: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 88

Table 141: CITATION Peripheral Stent System-Product Status 88

Table 142: CITATION Peripheral Stent System-Product Description 89

Table 143: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 90

Table 144: Peripheral Stent-Product Status 90

Table 145: Peripheral Stent-Product Description 91

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

3D Biotek LLC, 480 Biomedical Inc, Abbott Vascular Inc., Biotronik SE & Co KG, Boston Scientific Corp, C. R. Bard Inc, Cardiatis SA, Cook Medical Inc, Cordis Corp, Corinnova Inc, Cytograft Tissue Engineering Inc, Efferent Labs Inc, Electroformed Stents Inc, Elixir Medical Corp, Hexacath, InspireMD Inc, Intact Vascular, LLC, Lifetech Scientific (Shenzhen) Co., Ltd., LimFlow GmbH, Medinol Ltd, Medtronic plc, MicroVention, Inc., Natec Medical Ltd, Nexeon MedSystems Inc, Nipro Corp, Northwestern University, NSVascular, Inc., PeriTec Biosciences Ltd, Stron Medical, Synergy Flow Ltd, Taewoong Medical Co.,Ltd., Tepha Inc, TissueGen Inc, University of Michigan, University of Texas Medical Branch at Galveston, Vascular Bioresorbable Technologies, Vascular Concepts Ltd, Veniti Inc, Veryan Medical Limited, VueKlar Cardiovascular Ltd, Xenogenics Corporation

3D Biotek LLC, Bioresorbable Drug Eluting Peripheral Polymer Stent; 480 Biomedical Inc, Stanza Bioresorbable Pediatric Scaffold; 480 Biomedical Inc, Stanza Bioresorbable Self-Expanding Scaffold; Abbott Vascular Inc., ESPRIT Bioresorbable Vascular Scaffold; Biotronik SE &; Co KG, Astron Pulsar Self Expanding Peripheral Stent; Biotronik SE &; Co KG, Pulsar-18 Self Expanding Stent; Boston Scientific Corp, Cobalt-Chromium Iliac Balloon Expandable Stent; Boston Scientific Corp, Eluvia Drug-Eluting Vascular Stent System; Boston Scientific Corp, Gallbladder Drainage System; Boston Scientific Corp, Wallstent RP Endoprosthesis-Venous Outflow Obstruction; C. R. Bard Inc, VENOVO Venous Stent; Cardiatis SA, Cardiatis FluidSmart 3D Stent; Cook Medical Inc, Evolution Biliary Stent System-Partially Covered; Cook Medical Inc, Evolution Esophageal Stent System-Fully Covered; Cook Medical Inc, Zenith Connection Endovascular Covered Stent; Cook Medical Inc, Zenith Helical Branch Iliac Endovascular Graft; Cook Medical Inc, ZILVER PTX Drug Eluting Peripheral Stent; Cook Medical Inc, Zilver Vena Venous Self-Expanding Stent; Cordis Corp, FlexStent Femoropopliteal Self Expanding Stent System-SFA; Cordis Corp, FlexStent Self Expanding Below-The-Knee Venous Stent System; Cordis Corp, FlexStent Self Expanding Venous Stent System; Cordis Corp, Tibial SE FlexStent; Corinnova Inc, Hybrid Dynamic Stent; Cytograft Tissue Engineering Inc, LifeJacket Stent Graft-Peripheral; Efferent Labs Inc, RTI-LICD Plexisense; Electroformed Stents Inc, Helical Stent; Electroformed Stents Inc, Patch Stent; Electroformed Stents Inc, Pleated Stent; Elixir Medical Corp, PRAVA Bioresorbable Scaffold; Hexacath, HELIOS LD Peripheral Balloon Expandable Bio Active Stent; InspireMD Inc, PVGuard Peripheral; Intact Vascular, LLC, Tack Endovascular System-BTK; Lifetech Scientific (Shenzhen) Co., Ltd., Peripheral Bare Stent; Lifetech Scientific (Shenzhen) Co., Ltd., Peripheral Cover Stent; LimFlow GmbH, LimFlow Stent Graft System; Medinol Ltd, ChampioNIR; Medtronic plc, Maris; MicroVention, Inc., CASPER Carotid Stent; Natec Medical Ltd, Marina; Nexeon MedSystems Inc, CITATION Peripheral Stent System; Nipro Corp, Peripheral Stent; Northwestern University, 3D Printed Endovascular Stent; NSVascular, Inc., Micropatterned TFN Stent; PeriTec Biosciences Ltd, Periteneum-Lined Balloon-Expandable Stent; PeriTec Biosciences Ltd, Peritoneum Lined Self-Expanding Stent; Stron Medical, Biodegradable Biliary Stent; Stron Medical, Tracheobronchial Stent; Synergy Flow Ltd, ArtiStent; Taewoong Medical Co.,Ltd., Niti-S Bumpy Biliary Stent; Taewoong Medical Co.,Ltd., Niti-S Comvi Biliary Stent; Taewoong Medical Co.,Ltd., Niti-S Giobor Biliary Stent; Taewoong Medical Co.,Ltd., Niti-S Kaffes Biliary Stent; Taewoong Medical Co.,Ltd., Niti-S LCD Biliary Stent; Taewoong Medical Co.,Ltd., Niti-S Nagi Stent; Taewoong Medical Co.,Ltd., Niti-S S Biliary Covered Stent; Tepha Inc, TephaFLEX Fully Absorbable Peripheral Stent; TissueGen Inc, Archer Stent; University of Michigan, Tracheal Stent; University of Texas Medical Branch at Galveston, Intraluminal Stent With Seam; Vascular Bioresorbable Technologies, Drug Eluting Scaffold-Peripheral Artery Disease; Vascular Bioresorbable Technologies, Drug Free Pure Bioresorbable Scaffold-Peripheral Artery Disease; Vascular Concepts Ltd, Prograft SX; Vascular Concepts Ltd, ProStar; Vascular Concepts Ltd, Resistant; Veniti Inc, VICI Venous Stent; Veryan Medical Limited, BioMimics 3D Stent; Veryan Medical Limited, SwirlGrip; VueKlar Cardiovascular Ltd, MR-Enhancing Balloon Expandable Stent; VueKlar Cardiovascular Ltd, MR-Enhancing Self-Expanding Stent; Xenogenics Corporation, Ideal BioStent-Peripheral; Xenogenics Corporation, Unison Peripheral Stent System


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com